WHO Pharmaceuticals Newsletter 1998, No. 03&04
(1998; 18 pages)
Table of Contents
Open this folder and view contentsRegulatory actions
Close this folderDrug surveillance
View the documentAcetylsalicylic acid and NSAIDs - OTC availability: increased potential for adverse reactions
View the documentDrug-induced depression - review
View the documentMidazolam - paradoxical reactions in children
View the documentSelective serotonin reuptake inhibitors (SSRIs) - neonatal disorders
View the documentSumatriptan - fatal outcomes
View the documentVenlafaxine - review of adverse reactions
Open this folder and view contentsNew developments
View the documentRecent approvals
Open this folder and view contentsMedical devices
Open this folder and view contentsGeneral information
Open this folder and view contentsVeterinary medicine
 

Drug-induced depression - review

Australia. In the seven-year period from 1990 to 1996, the Adverse Drug Reactions Advisory Committee has received 454 reports of depression as a suspected adverse reaction to therapeutic medicines. In 406 of these reports there was no evidence suggesting pre-existing depression.

For these 406 reports, ages ranged from 4 to 95 years (median: 50) and onset varied from one day to 9 months. A single drug was implicated in 92% of the reports and in 36 of these the association was considered probable because the symptoms recurred on rechallenge. Recovery following withdrawal of the suspected drug(s) was documented in more than 70% of the reports. Ten reports noted that the patient had been hospitalized because of depression. Suicide attempts were described in 19 of the reports and two fatal outcomes were documented. The drugs most commonly reported were:

Drug Reports Reports per million prescriptions

Mefloquine

15

148.5

Vigabatrin

6

52.0

Dexfenfluramine

14

21.3

Ciprofloxacin

6

9.3

Pravastatin

7

6.0

Simvastatin

53

4.0

Gemfibrozil

7

3.8

Nicotine transdermal

5

3.8

Prescribers should be aware of the possibility of drug-induced depression which can sometimes be severe. If the temporal relationship is suggestive, withdrawal of a possible precipitating drug should be tried before the initiation of antidepressants.

Reference: Australian Adverse Drug Reactions Bulletin 17(1): 3 (1998).

to previous section to next section
 

Last updated: May 3, 2013